News
>
BBV154
BBV154
Advertisement
Bharat Biotech completes clinical trials of India's first intranasal vaccine
Bharat Biotech’s intranasal jab gets DCGI’s approval for booster dose trials
1188048
1
0
topics
Subscribe Now
×
Enroll for our free updates
Please enter full name.
Please enter valid email address.
https://zeenews.india.com/
Subscribe Now
Thank you
NEWS ON ONE CLICK
)
)
